title: The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.
authors.affiliation: Stanford University Hospital, CA.
authors.forename: G
authors.initials: G
authors.lastname: Visani
authors.forename: B
authors.initials: B
authors.lastname: Gamberi
authors.forename: P
authors.initials: P
authors.lastname: Greenberg
authors.forename: R
authors.initials: R
authors.lastname: Advani
authors.forename: S
authors.initials: S
authors.lastname: Gulati
authors.forename: R
authors.initials: R
authors.lastname: Champlin
authors.forename: M
authors.initials: M
authors.lastname: Hoglund
authors.forename: C
authors.initials: C
authors.lastname: Karanes
authors.forename: S
authors.initials: S
authors.lastname: Williams
authors.forename: A
authors.initials: A
authors.lastname: Keating
mesh_terms: D016026:Bone Marrow Transplantation; D004311:Double-Blind Method; D006085:Graft Survival / Q000187:drug effects; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D009369:Neoplasms / Q000601:surgery; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
chemical_list: D007155:Immunologic Factors; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor